Document:

Offer Letter dated August 18, 2011

 Exhibit 10.1 
 

 
 30831 Huntwood Avenue, Hayward, CA 94544 
 (510) 476-2000 Fax (510) 471-3200 
 www.impaxlabs.com 

August 18, 2011 
 Ms. Carole Ben-Maimon, M.D. 

359 Brookway Rd. 
 Merion Station, PA 19066 

OFFER OF EMPLOYMENT 
 (REVISED)

 Dear Carole, 
 This letter constitutes an offer of
employment for you to join Impax Laboratories, Inc. (IMPAX) as the President, Generic Products Division (Global Pharmaceuticals). In this position you will report to Larry Hsu, PhD., President and CEO. You will be based out of our Chalfont, PA
office. 
 In this position your salary will be $18,076.92 paid biweekly ($470,000.00 annually). 
 You will be eligible to participate in the Impax management bonus program, under which, for each full calendar year, you would be eligible for a bonus targeted at 60% of your base salary and potentially up to 90%
of your base salary, in each case depending on the achievement of certain business and individual objectives and criteria. 
 Your potential bonus for
2011 will be prorated depending on your start date. In addition Impax will pay you a one-time cash payment for 2011, concurrent with the timing of any bonus payments for 2011, in the amount of the difference between the prorated bonus amount you are
entitled to under the Impax management bonus program and the amount that you would have been entitled to had you been employed with Impax for 6 (six) months of the year of 2011. 
 Subject to Board of Directors approval, Impax will award to you: (i) an option to purchase 75,000 shares of Impax common stock, (ii) 24,000 shares of Restricted Stock, in each case subject to our normal
vesting schedule of 25% per year starting on the first anniversary of the grant, so long as you remain employed by Impax (these grants are subject to Board of Directors approval and this proposal is not a intended to create any obligation on
the part of Impax or its Board of Directors — further details on our equity plans and any specific awards grant to you will be provided following approval of such awards by our Board of Directors). 

Impax will also pay you a one-time hiring bonus of $75,000.00 (less applicable taxes and other required withholdings). This hiring bonus will be paid as follows:
$37,500.00 after thirty (30) days of employment, $37,500.00 on the first payroll date following the first anniversary of your employment with Impax. 

Should your employment with IMPAX be terminated voluntarily or for cause, within a one-year period of your hire date, you will be required to repay the Company100%
of the sign-on bonus paid to you to date. Should your employment with IMPAX be terminated voluntarily or for cause, within the second year period of your hire date, you will be required to repay the Company 50% of the sign-on bonus paid to you to
date. 

 

 
 Your employment start with IMPAX will be a date mutually agreed between you and the Company, and is currently anticipated to be
no later than September 6, 2011. Once there is an agreed start date with the Company you should plan to report for New Hire Orientation at 8:30 am in our Hayward offices at 31047 Genstar Rd., Hayward, CA 94544 on your first day. 

You will be eligible for benefits in accordance with the applicable Impax policies for executives, including: 

 

	 	•	 	 medical and dental insurance coverage starting the first of the month following your date of employment; 

 

	 	•	 	 group term life, and group long-term and short-term disability insurance coverage starting the first of the month following three months of employment;

  

	 	•	 	 participation in the Impax 401(k) Plan on the first day of the first calendar quarter following one month of employment; 

 

	 	•	 	 participation in the Impax Executive Non-Qualified Deferred Compensation Plan; 

 

	 	•	 	 accrual of up to sixteen (16) days of Paid Time Off (PTO) that accrue on a weekly basis (PTO cannot be used until it is earned); and

  

	 	•	 	 a one-time allowance of four (4) days paid time off for two occasions: September 28, 29, 30, 2011, and October 7, 2011.

 You will be entitled to participate in or receive benefits under any other employee benefit plan made available by the company in the
future to its employees subject to, and on a basis consistent with, the terms, conditions and overall administration of such plans. 
 Please note that
this employment offer is contingent upon a successful completion of a drug test, background check and credit check paid by the Company. Information regarding drug testing will be provided to you at the point you choose to accept this offer. An
Authorization Form and picture ID are required for testing. A positive result will mandate the rescission of this offer. 
 To comply with the Department
of Justice Immigration and Control Act, you will need to provide documentation that supports employment eligibility within the United States. Please bring your documentation with you on your Orientation Day. If you would like a list of acceptable
documents, please contact Human Resources. Please bring a voided check or savings account document if you are interested in Payroll Direct Deposit. 

Please note that your employment is at will. Accordingly, either you or the company can terminate the employment relationship at any time, with our without advance
notice. This offer does not constitute any promise or obligation of any duration of employment nor severance package. If this offer is acceptable, please return the signed original document to me in Human Resources. You can also respond initially by
confidential fax at 510-429-2146. 

  
 Page 2 of 3 

 

 
 Carole, we believe that you will contribute to the company’s overall success and that IMPAX will provide you the career
environment and opportunities that you seek. We look forward to your joining the IMPAX team. If you have any questions please contact Human Resources at 510-240-6045. 
  

			
	Sincerely,
		
		 	/s/ Paul R. Ulatoski
		 	Paul R. Ulatoski
		 	Vice President Human Resources
		 	Impax Laboratories, Inc.

 CC: Larry Hsu 
 Accepted by:

  

					
	/s/     Carole Ben-Maimon        	 		 	August 18, 2011
	 Carole Ben-Maimon
	 		 	Date

  
 Page 3 of 3Sale and Supply Agreement

 Exhibit 10.1 
 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. 
 Confidential Treatment Requested Under 
 17 C.F.R. Sections
200.80(b)(4) and 240.24b-2 
 Sale and Supply Agreement 

This Sales and Supply Agreement (“Agreement”) is entered into and is effective as of the last date of signature found below
(the “Effective Date”), by and between Illumina Inc., a Delaware corporation, having a place of business at 9885 Towne Centre Drive, San Diego, CA 92121 (“Illumina”), and Sequenom Inc., a Delaware corporation, having a
place of business at 3595 John Hopkins Court, San Diego CA, 92121 (hereinafter “Customer”). 
 Recitals

 1. Customer will have the [...***...] use the goods sold hereunder for research and for providing a commercial service in
its clinical laboratory that is licensed under the Clinical Laboratory Improvement Amendments (“CLIA”) for the detection of fetal chromosomal abnormalities as defined and set forth below. Other non research applications may be added by
written agreement of the parties. 
 2. Customer acknowledges that these goods have not been cleared by the FDA or any other regulatory body for
its intended uses. 
 3. The parties intend to work collaboratively to generate the evidence necessary to support an eventual submission by
Customer of an in vitro-diagnostic product for the detection of fetal chromosomal abnormalities. 
 Agreement 

1. Definitions. 
  

	 	a.	“Approved Applications” means a use of Goods for a Clinical Use [...***...]. [...***...] the cell-free detection of Fetal
Chromosomal Abnormalities from maternal blood or maternal blood components. 

  

	 	b.	“Clinical Use” means the generation of data that will be used to inform an individual, directly or indirectly, about such
individual’s/fetus’s genomic information, condition, or healthcare treatment. 

  

	 	c.	“Consumables” means all Goods for use with, and to be consumed through the use of Hardware and provided hereunder as specified in Exhibit A.

  

	 	d.	“Derivative Software” means any derivative or modification of Software made by Customer as may be permitted by the relevant EULA.

  

	 	e.	“Discontinued Consumables” means any Consumables previously offered on a general commercial basis to all Illumina customers and purchased hereunder,
but that will no longer be offered to all Illumina customers. 

  

	 	f.	“Documentation” means user manuals, protocols or other documentation provided by Illumina under this Agreement or in connection with the Goods and
related to the use and maintenance of the Goods. 

  

	 	g.	“EULA” means the software end user license agreement for Software. 

 

	 	h.	“Facility” means the Customer facility or a Subsidiary facility, as applicable, located at the shipping address identified on the Purchase Order, which
shall be [...***...]. 

  

	 	i.	“Fetal Chromosomal Abnormalities” means [...***...] 

  

					
		 		 	***Confidential Treatment Requested
		 	1	 	
		 	CONFIDENTIAL	 	

 [...***...]. 

 

	 	j.	“Firm Forecast” is as defined in Section 6.a. 

  

	 	k.	“Forecast” is as defined in Section 6.a. 

  

	 	l.	“Goods” means any and all of the Consumables, Hardware, Software, and other items provided hereunder. 

 

	 	m.	“Hardware” means the Instruments, accessories or peripherals, and other hardware, as specified in the Specifications. 

 

	 	n.	“Instrument” means equipment provided hereunder as specified in Exhibit A. 

 

	 	o.	“Intellectual Property Rights” means all patent rights, copyrights, trade secrets, know-how, trademark, service mark and trade dress rights and other
intellectual property rights, current or future, under the laws of any jurisdiction, together with all applications therefore and registrations thereto. 

  

	 	p.	“Purchase Order” means the written orders for Goods submitted to Illumina by Customer pursuant to this Agreement. 

 

	 	q.	“Research Use” means experimentation intended to develop or investigate scientific or medical knowledge, which includes such uses conducted in exchange
for a fee and the delivery of data to a third party, but expressly excluding Clinical Use. 

  

	 	r.	“Software” means the Software provided under this Agreement, or as updates or options under future agreements, or as incorporated or embedded in
Hardware or components thereof or otherwise provided under this Agreement whether or not there is a separate charge therefor, including any Software that is provided from a third party. All references in this Agreement to the “purchase” or
“sale” of Software shall mean the acquiring or granting, respectively, of a license to use such Software to exercise the rights pertaining to such Software that are expressly set forth herein. The Software provided as of the Effective Date
is identified in Exhibit A to this Agreement. 

  

	 	s.	“Specifications” means the written specifications for Goods that are contained in the Documentation, and/or other written materials in effect for the
Goods on the Effective Date or as may be revised pursuant to the terms of this Agreement. 

  

	 	t.	“Subsidiary or Subsidiaries” means an entity or organization that is under the control of Customer where control means the possession of the power to
direct or cause the direction of the management and the policies of an entity, whether by direct or indirect ownership of a majority of the voting stock or interest in an entity, control of a majority of the composition of the board of directors, by
contract, or otherwise. 

 2. Rights Conferred upon Customer. Subject to the terms and conditions of this Agreement,
including the limitations in this Section 2, Customer’s purchase of the Goods confers upon Customer a [...***...] right under Illumina’s Intellectual Property Rights in the Goods, to use those Goods, solely for
(i) Research Use, and (ii) Approved Applications. The phrase “Illumina’s Intellectual Property Rights in the Goods” means only those Intellectual Property Rights of Illumina that are applicable to the general functionality
of the Goods. Customer acknowledges that Illumina’s Intellectual Property Rights in the Goods expressly excludes [...***...]. By way of non-limiting examples, the Intellectual Property Rights in the Goods conferred in this
Section 2 expressly excludes any Intellectual Property Rights with respect to [...***...]. Consistent with that and subject to paragraphs a and b of this Section 2, Customer further acknowledges that its use of the Goods
[...***...]  

  

					
		 		 	***Confidential Treatment Requested
		 	2	 	
		 	CONFIDENTIAL	 	

 
[...***...]. It is solely Customer’s responsibility to ensure it has all rights necessary for its intended use of the Goods. The Goods may be covered by one or more U.S. or
foreign patents. 
  

	 	a.	The Intellectual Property Rights of Illumina are numerous, diverse, and rapidly changing, and Sequenom does not know with certainty the metes and bounds of every right
included therein as of the Effective Date. Subject to the preceding sentence, and in reliance on Illumina’s representation and warranty below, Customer represents and warrants that, [...***...]. 

 

	 	b.	The Intellectual Property Rights of Illumina are numerous, diverse, and rapidly changing, and Illumina does not know with certainty the metes and bounds of every right
included therein as of the Effective Date. Subject to the preceding sentence, and in reliance on the Customer’s representation and warranty above, [...***...] Illumina represents and warrants that, [...***...].

 3. Applicability of Terms and Conditions. This Agreement shall exclusively govern the ordering, purchase and supply of
the Goods, and shall override any conflicting, amending and/or additional terms contained in any purchase orders, invoices or similar documents, which are hereby rejected and shall be null and void. Illumina or Customer’s failure to object to
any such terms shall not constitute a waiver by Illumina or Customer, nor constitute acceptance by Illumina or Customer of such terms and conditions. For clarity, Subsidiaries of Customer are permitted to purchase and use Goods hereunder; provided
that, (i) such Subsidiaries are subject to and adhere to all of the terms and conditions of this Agreement and shall be directly liable to Illumina with respect thereto, and (ii) Customer shall remain wholly liable for the acts or
omissions of its Subsidiaries in connection with or arising out of this Agreement. 
  

	 	a.	Applicability of Terms to Previously Purchased Instruments. Sections 2, 15, 16, 18, 19, 20, 22, 23, 25, and 31 of this Agreement shall apply to those
[...***...] instruments purchased by Customer and listed in Appendix II (“Pre-Purchased Instruments”). All other terms of this Agreement do not apply to the Pre-Purchased Instruments. In the event of conflict between the
terms of this Agreement that apply to the Pre-Purchased Instruments and the terms under which they were sold by Illumina to Customer, the terms of this Agreement that do apply shall control and supercede. 

4. Installation.  
  

	 	a.	Installation Cost. Illumina shall install Instruments ordered hereunder at the Facility. Subject to the terms and conditions of this Agreement, the cost of such
installation is [...***...]. Illumina, or its designee, will use [...***...] efforts to schedule and complete installation within [...***...] ([...***...]) days of delivery of all of the components
comprising such Instrument to the Facility. Illumina will provide Customer with any predefined specifications or requirements for the installation of the Instrument. If, [...***...], the Facility does not meet Illumina’s predefined
specifications or requirements for the installation of such Instrument, Customer agrees [...***...] to bring the Facility within such compliance for installation of such Instrument. 

 

	 	b.	Testing upon Installation. Upon installation of an Instrument, Illumina shall perform the testing of such Instrument as set forth in Exhibit C to ensure such
Instrument conforms with its Specifications. Upon Illumina’s completion of such testing, installation shall be complete. 

5. Shipping Terms; Title and Risk of Loss. Goods shall be delivered FOB destination to the Facility designated on the Purchase Order.
Illumina’s title to Goods (except for Software) and risk of loss or damage thereto shall pass to Customer at the time of Illumina’s delivery of such Goods to such Facility. All prices are [...***...]. All prices and other
amounts payable to Illumina under this Agreement are [...***...] 

  

					
		 		 	***Confidential Treatment Requested
		 	3	 	
		 	CONFIDENTIAL	 	

 
[...***...]. In the event Illumina is required, by applicable law or regulation, [...***...]. [...***...]. 

6. Forecast. 
  

	 	a.	Forecast. No later than [...***...] ([...***...]) calendar days prior to the beginning of each calendar quarter, Customer shall provide
Illumina with a written forecast, detailed on a quarterly basis, and including the quantity of Consumables [...***...] that Customer intends to purchase from Illumina during the [...***...] ([...***...]) months
following the beginning of such calendar quarter (the “Forecast”). Subject to the terms and conditions of this Agreement, the first [...***...] ([...***...]) months of each accepted Forecast shall be a binding
commitment for Customer to purchase and for Illumina to sell and timely deliver the quantity of Consumables identified in such [...***...] ([...***...]) month period (the “Firm Forecast”).

  

	 	b.	Changes to Forecast. Customer may provide a revised Forecast at any time; provided that, Customer may revise the Firm Forecast portion of a Forecast only
[...***...] that shall take place no later than [...***...]. Customer may only revise the quantity of Consumables to be ordered during the Firm Forecast by [...***...]. Illumina will work in good-faith with
Customer to support any increases in demand that exceed such [...***...] increase. 

 7. Initial [...***...]
Consumables. 
  

	 	a.	[...***...] samples. Illumina shall ship and Customer shall take receipt of [...***...] samples worth of [...***...] Consumables,
as detailed by specific kits in Appendix I, by [...***...]. Illumina shall invoice Customer for such [...***...] Consumables pursuant to the invoicing term of this Agreement. 

 

	 	b.	[...***...] samples. Illumina shall ship and Customer shall take receipt of an additional [...***...] samples worth of [...***...]
Consumables, as detailed by specific kits in Appendix I, by [...***...]. In order to secure for Customer this supply of “raw” [...***...] flowcells, these [...***...] Consumables will be
manufactured in a single lot per kit type and shipped to Customer in a single lot per kit type. Customer shall [...***...]% of the purchase price of these [...***...] Consumables plus pay [...***...], for which
Illumina shall invoice Customer after [...***...]. The balance shall be invoiced upon shipment of these [...***...] Consumables. 

  

	 	c.	[...***...]; Shelf-life; Non-Cancelable/Non-Refundable. Customer acknowledges that unless otherwise agreed by the parties in writing, [...***...]
will be available. The commitments made by Customer under this Section 7 are non-cancelable and non-refundable provided that the [...***...] Consumables conform to the Specifications for the duration of their warranty period.
All [...***...] Consumables ordered under this Section 7 shall have the equivalent of no less than [...***...] ([...***...])[...***...] shelf life at the time of shipment.

 8. Initial Instruments. Illumina shall ship and Customer shall take receipt of [...***...] and
[...***...] during each of [...***...]. 
 9. Minimum Annual Purchase. Beginning [...***...], in
the event Customer’s aggregate calendar year purchases of Consumables drops below $[...***...] (such amount being net of any discounts), then Illumina will be relieved of its obligations and representations with respect to
Discontinued Consumables, [...***...]. 
 10. Illumina Technology. In the event Customer uses a third party’s
sequencing technology in lieu of the Goods for the Approved Applications, then Illumina will be relieved of its obligations and representations with respect to Discontinued Consumables, [...***...]. 

  

					
		 		 	***Confidential Treatment Requested
		 	4	 	
		 	CONFIDENTIAL	 	

 11. Price. 
  

	 	a.	Commercially Produced Goods Pricing. Subject to the Discontinued Goods pricing section below, the purchase price for Goods ordered hereunder shall be as set
forth in Exhibit A. 

  

	 	b.	Discontinued Consumable Pricing. The purchase price for Discontinued Consumables, if they will be made available to Customer, will be determined at the time of
discontinuation. 

 12. Purchase Orders; Lead Times; Delivery. Customer agrees to use written Purchase Orders when ordering
Goods under this Agreement; provided that the shipment of the initial [...***...] referred to in Section 8, and the [...***...] Consumables referred to in Section 7, will take place pursuant to the schedule set
forth in Sections 7 and 8. Illumina shall be deemed to have accepted a Purchase Order if it has not rejected it within [...***...] ([...***...]) business days of its receipt; provided that, Purchase Orders meeting the terms
and conditions of this Agreement and ordering Consumables pursuant to an accepted Firm Forecast may not be rejected. Purchase Orders shall be sent to the attention of Illumina Customer Solutions or to any other person or department designated by
Illumina. Purchase Orders shall state, at a minimum, the Illumina part number for Goods, quantity ordered, price, and Facility. Delivery dates for Goods ordered hereunder will be mutually agreed upon at the time of ordering. Goods falling under Firm
Forecasts shall be considered to have been delivered on-time if they arrive no sooner than [...***...] ([...***...]) business days earlier and no later than [...***...] ([...***...]) business days
later than as mutually agreed upon; provided that, all Instrument orders and all other orders will be delivered as mutually agreed. 
 13.
Invoices; Payment. Illumina shall issue invoices upon shipment of Goods hereunder. Payments shall be sent to Illumina’s accounts receivable department, or any other address designated by Illumina. All payments by Customer are due within
[...***...] ([...***...]) days of the date of the invoice, provided that Customer has not disputed any amounts under the invoice by written notice to Illumina. For undisputed amounts under invoices, any amounts not paid
when due will accrue interest at the rate of [...***...] percent ([...***...]%) per month, or the maximum amount allowed by law, if lower. In the event that any payment is not made with respect to an undisputed amount under
an invoice within the time period specified in this Agreement, Illumina shall have the right to revoke the rights conferred and/or licenses given hereunder and suspend performance, including shipment, until all payments are made current. Customer
shall pay for all costs (including reasonable attorneys’ fees) incurred by Illumina in connection with the collection of late payments. The amount of credit may be changed or credit withdrawn by Illumina at any time. Each Purchase Order is a
separate, independent transaction, and Customer has no right of set-off against other purchase orders or other transactions with Illumina. 

14. [...***...]. The parties acknowledge both that Customer will be validating its assays based upon the specific Goods listed in Exhibit A
and Appendix 1, [...***...]. In cases where a Consumable purchased hereunder [...***...], Illumina shall take commercially reasonable efforts to provide Customer with a minimum of [...***...] advance notice prior to
[...***...] and provide Customer with a minimum of [...***...]. [...***...] Consumable found in Exhibit A must be compatible with the Hardware and Software set forth in Exhibit A; provided that, Customer has
maintained any updates or upgrades to such Hardware and Software that would be mandatory for [...***...] supply Discontinued Consumables hereunder and in such cases Illumina bears no liability to Customer for such discontinuation. In
cases where it is possible and practical for Illumina to [...***...] as reasonably determined by Illumina, and Customer has used commercially reasonable efforts to [...***...]: 

Lot Purchases [...***...]. Illumina will continue to sell [...***...]; provided that, Customer will be required
to purchase such [...***...]. Pricing, lead times, warranty terms, support, and any other applicable terms for such [...***...] will be agreed upon in writing at the time of

  

					
		 		 	***Confidential Treatment Requested
		 	5	 	
		 	CONFIDENTIAL	 	

 
[...***...]; provided that, pricing will be commensurate with pricing under this Agreement taking into consideration all factors involved with making [...***...].
 
 In cases where Customer desires to begin purchasing a substitute Consumable, it may do so under the following terms: 

Substitute Consumables. Pricing, lead times, warranty terms, support, and any other applicable terms for such substitute Consumable will
be agreed upon in writing at the time of adding the substitute Consumable to this Agreement. 
 15. Validation. Customer shall,
[...***...] responsible for validating all Goods including Software for its particular uses, including any substitute products and modified products provided hereunder. 
 16. Regulatory; Other Terms. 
  

	 	a.	Research Use Only. Customer acknowledges that the Goods have not been subjected to regulatory review or approved or cleared by the FDA or any other regulatory
entity, or otherwise reviewed, cleared or approved under any statute, law, rule or regulation for any purpose, whether research, commercial, diagnostic or otherwise. 

 

	 	b.	Notwithstanding Illumina’s consent for Customer to use the Goods in any given Approved Application, Illumina makes no claim, representation, or warranty of any
kind as to the utility of the Goods for such use including, without limitation, whether the regulatory status of the Goods is appropriate for Customer’s use. Customer is solely responsible for determining the utility and fitness of the Goods
for its uses. The parties agree that based upon the final regulatory status of the Goods, this clause will be modified as appropriate given the approved indication of use. Nothing set forth in this Section 16(b) shall limit Illumina’s
warranties in Sections 26, 27, and 29. 

  

	 	c.	Regulatory Approvals. Customer is solely responsible for obtaining any and all regulatory approvals and licensure necessary for its intended uses of the Goods. To that
end, the parties agree that the Goods shall be used, in addition to the purposes described in Section 2 above, to generate clinical and other evidence necessary to support an eventual FDA submission by Customer for Clinical Uses using the
Goods. The parties agree to 1) work together to develop a regulatory strategy to support an eventual FDA submission and to make adjustments as mutually agreed to meet this objective, and 2) keep each other reasonably informed about the regulatory
strategy and status thereof as it relates to the subject matter of this Agreement. The parties acknowledge and agree that Customer will be seeking regulatory approval for certain of its products utilizing one or more of the Goods (the “PMA
Products”) and agree to negotiate in good faith either modifications to this Agreement and/or the terms and conditions of a new agreement setting out, among other things, each party’s specific regulatory responsibilities and obligations
with respect to the PMA Products and the Goods utilized in connection therewith. 

  

	 	d.	Implementation of New Illumina Product with Appropriate Regulatory Status. In the event Illumina offers a Consumable product (including combination of Consumables) that
is substantially equivalent to those purchased hereunder and that has a regulatory status (e.g., IVD, GPR, etc.) that, [...***...], is more appropriate given Customer’s intended use of the item purchased hereunder, then Customer
shall attempt to validate such new product using [...***...] efforts and then implement that new product within [...***...] ([...***...]) months of Illumina making such Consumable product available to Customer;
provided that, Customer may delay implementation of such new product that has been successfully validated if Customer notifies Illumina in writing that it will need regulatory approval for such implementation and in such case Customer shall
implement the new Consumable product upon receipt of such regulatory approval. In the event Customer determines it will need regulatory approval for such implementation, Customer shall use [...***...] efforts to submit such new
Consumable product to the appropriate regulatory agency within [...***...] ([...***...]) months of Illumina making such Consumable product available to Customer and Customer shall implement the new Consumable product upon
receiving the appropriate clearance or approval from the regulatory agency. Customer agrees to diligently pursue regulatory approval for such new Consumable. 

  

					
		 		 	***Confidential Treatment Requested
		 	6	 	
		 	CONFIDENTIAL	 	

	 	e.	Disclosures. Customer will disclose to Illumina in a timely manner any communication, oral or written, that it receives from the FDA (or its foreign counterparts)
regarding the use of any Illumina products or the business relationship between Customer and Illumina. Illumina will disclose to Customer in a timely manner any communication, oral or written, that it receives from the FDA (or its foreign
counterparts) regarding Customer’s use of any Illumina products or the business relationship, including any that may reasonably be considered to affect the continuity of supply of Goods to Customer, between Customer and Illumina. If either
party receives any of the preceding communications, the parties will work together jointly to address any concerns raised by FDA (or its foreign counterpart) therein. 

 

	 	f.	Compliance with Law. Customer and Illumina each have the right to cease performance under the Agreement, including without limitation, the sale of Consumables under the
Agreement, and without liability to the other (except for payment for Goods and services delivered up to that date), in the event that either party is notified by the FDA (or an agency under the Federal Health and Human Services) or any foreign
equivalent that such performance is illegal or violates any law or order including, without limitation, any FFDCA law, FDA regulation, order, or similar action; provided that, [...***...]. 

 

	 	g.	[...***...]. [...***...] per [...***...] and only after providing [...***...] prior written notice, Customer may at its
sole expense [...***...]. [...***...] following submission of an FDA application by Customer [...***...]. Notwithstanding any provision of this Agreement to the contrary, all information disclosed or observed
[...***...] shall be the confidential information of Illumina regardless of form and may not be disclosed to any third party or used in any manner without the prior written consent of Illumina. In the case of a specific and material
quality issue with a Good purchased hereunder, Illumina shall, on a case-by-case basis, work with Customer on [...***...]. 

  

	 	h.	Training and Customer Audits. The parties agree that it is important to maintain the highest possible levels of quality both from Illumina’s supply side and in
connection with Customer’s use of the Goods purchased hereunder. Accordingly, Customer agrees to undertake any training for the use of the Goods that Illumina may reasonably request. Customer further agrees to allow Illumina to audit Customer
no more frequently than once per year in order to verify its personnel’s proficiency in the use of the Goods. The Facilities, times, and dates for such proficiency audits will be mutually agreed upon. 

 

	 	i.	[...***...] 

  

	 	j.	Illumina Manufacturing and Shipping Facilities. All Goods are currently manufactured and shipped from one or more of the facilities listed in Exhibit B. Illumina may
manufacture or ship Goods from additional or different facilities in the future. Upon written request of Customer, Illumina will provide any updates to Exhibit B. 

 17. [...***...]. Illumina represents that on the Effective Date, [...***...]; provided that, [...***...] is expressly authorized in writing by Illumina to use such
product for Clinical Use, [...***...] and to test for [...***...]. 

  

					
		 		 	***Confidential Treatment Requested
		 	7	 	
		 	CONFIDENTIAL	 	

 On [...***...] of this Agreement, and every [...***...]
([...***...]) months thereafter during the Term, Illumina shall [...***...] offered under this Agreement during the preceding [...***...] ([...***...]) month period and purchases by customers
that meet the criteria in the preceding paragraph of this Section 17. After such review, [...***...]. 
 18. Instrument
Standards. Each Instrument and Hardware provided hereunder shall comply with the normative safety and EMC general requirements for Electrical Equipment for Measurement, Control and Laboratory Use. 

19. Limitation of Liability. 
  

	 	a.	TO THE EXTENT PERMITTED BY LAW, IN NO EVENT SHALL CUSTOMER BE LIABLE TO ILLUMINA OR ANY OF ITS AFFILIATES FOR LOST PROFITS, DATA OR BUSINESS, OR FOR ANY INDIRECT,
SPECIAL, INCIDENTAL, EXEMPLARY, CONSEQUENTIAL, OR PUNITIVE DAMAGES OF ANY KIND ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY (WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY OR
OTHERWISE). CUSTOMER’S TOTAL AND CUMULATIVE LIABILITY ARISING UNDER OR IN CONNECTION WITH THIS AGREEMENT, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY OR OTHERWISE, SHALL [...***...]; PROVIDED, HOWEVER, THAT
SUCH LIMITATION SHALL NOT APPLY TO [...***...]. THE LIMITATIONS SET FORTH IN THIS SECTION SHALL APPLY EVEN IF ILLUMINA OR ITS SUPPLIERS HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL
PURPOSE OF ANY LIMITED REMEDY. 

  

	 	b.	TO THE EXTENT PERMITTED BY LAW, IN NO EVENT SHALL ILLUMINA OR ITS SUPPLIERS BE LIABLE TO CUSTOMER OR ANY THIRD PARTY FOR COSTS OF PROCUREMENT OF SUBSTITUTE PRODUCTS OR
SERVICES, LOST PROFITS, DATA OR BUSINESS, OR FOR ANY INDIRECT, SPECIAL, INCIDENTAL, EXEMPLARY, CONSEQUENTIAL, OR PUNITIVE DAMAGES OF ANY KIND ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY (WHETHER
IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY OR OTHERWISE). ILLUMINA’S TOTAL AND CUMULATIVE LIABILITY ARISING UNDER OR IN CONNECTION WITH THIS AGREEMENT, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY OR
OTHERWISE, SHALL [...***...]; PROVIDED, HOWEVER, THAT SUCH LIMITATION [...***...]. THE LIMITATIONS SET FORTH IN THIS SECTION SHALL APPLY EVEN IF ILLUMINA OR ITS SUPPLIERS HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES, AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. 

 20. Limited Warranties. EXCEPT FOR
THE EXPRESS LIMITED WARRANTIES SET FORTH IN SECTIONS 26, 27, AND 29 OF THIS AGREEMENT, ILLUMINA MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE GOODS OR ANY SERVICES PROVIDED IN CONNECTION WITH THIS AGREEMENT, INCLUDING
WITHOUT LIMITATION ANY IMPLIED WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR ARISING FROM COURSE OF PERFORMANCE, DEALING, USAGE OR TRADE. 
 21. Confidentiality. 

  

					
		 		 	***Confidential Treatment Requested
		 	8	 	
		 	CONFIDENTIAL	 	

	 	a.	Confidential Information. The parties acknowledge that, by virtue of the activities to be performed and the relationships created under this Agreement, each
party (the “Recipient Party”) may have access to information that the other party (the “Disclosing Party”) considers to be confidential (“Confidential Information”). Confidential Information may include, but shall not
be limited to, inventions, designs, formulas, algorithms, trade secrets, know-how, customer lists, cost and pricing information, business and marketing plans, and other business and financial information. Each party is under no obligation to provide
or disclose Confidential Information that is not necessary in the performance of this Agreement. For a period of [...***...] ([...***...]) years after the date of disclosure, the Recipient Party shall hold the Disclosing
Party’s Confidential Information in confidence using the degree of care that is used by the Recipient Party with respect to its own Confidential Information (but no less than [...***...]). The Recipient Party shall only disclose
the Confidential Information of the Disclosing Party on a need to know basis to its employees and contractors under nondisclosure terms consistent with this Agreement, and those of its wholly-owned affiliates. The Recipient Party shall not use the
Disclosing Party’s Confidential Information for any purpose other than as contemplated by this Agreement. The Confidential Information at all times remains the property of the Disclosing Party. Upon the termination or expiration of this
Agreement, the Recipient Party shall, upon written request of the Disclosing Party, return to the Disclosing Party or destroy the Confidential Information. Notwithstanding the foregoing, the Recipient Party may maintain one copy of the Disclosing
Party’s Confidential Information to be retained by the Recipient Party’s Legal Department for archival purposes only. 

  

	 	b.	Exceptions. Notwithstanding any provision contained in this Agreement, neither party shall be required to maintain in confidence any of the following
information: (1) information that, at the time of disclosure to the Recipient Party, is in the public domain through no breach of this Agreement or another obligation of confidentiality owed to the Disclosing Party or its wholly-owned
affiliate; (2) information that, after disclosure hereunder, becomes part of the public domain by publication or otherwise, except by breach of this Agreement or another obligation of confidentiality owed to the Disclosing Party or a
wholly-owned affiliate; (3) information that was in the Recipient Party’s possession at the time of disclosure hereunder by the Disclosing Party unless subject to an obligation of confidentiality owed to the Disclosed Party or its
wholly-owned affiliate; (4) information that is independently developed by or for the Recipient Party; or (5) information that the Recipient Party receives from a third party where Recipient Party [...***...] such third party
was under no obligation of confidentiality to the Disclosing Party with respect to such information. 

  

	 	c.	Disclosures Required by Law. The Recipient Party may disclose the Disclosing Party’s Confidential Information as required by court order, operation of law,
or government regulation, provided that the Recipient Party promptly notifies the Disclosing party of the specifics of such requirement prior to the actual disclosure or promptly thereafter if prior disclosure is impractical under the circumstances,
uses [...***...] efforts to limit the scope of such disclosure or obtain confidential treatment of the Confidential Information, and allows the Disclosing Party to participate in the process undertaken to protect the confidentiality of
the Disclosing Party’s Confidential Information including, without limitation, cooperating with Disclosing Party in order to comply with the requirements of such order, law, or regulation in a manner that discloses the least amount, if any, of
the Confidential Information of the Disclosing Party. 

  

	 	d.	Injunctive Relief. Each party acknowledges that any use or disclosure of the other party’s Confidential Information other than in accordance with this
Agreement may cause irreparable damage to the other party. Therefore, in the event of any such use or disclosure or threatened use or threatened disclosure of the Confidential Information of either party hereto, the non-breaching party shall be
entitled, in addition to all other rights and remedies available at law or in equity, to injunctive relief against the breach or threatened breach of any obligations hereunder. 

 

	 	e.	 Disclosure of Agreement. Notwithstanding anything in this Agreement to the contrary and except to the extent that disclosure of this Agreement
and/or its terms are required by Securities and Exchange Commission regulation or law (“SEC Rules”), neither party may disclose this Agreement, the terms of this Agreement, including any financial terms thereof, and the subject matter of
this Agreement to any third 

  

					
		 		 	***Confidential Treatment Requested
		 	9	 	
		 	CONFIDENTIAL	 	

	 	
party without the prior written consent of the other party that will not be unreasonably withheld. Notwithstanding a party’s right to disclose this Agreement, the terms of this Agreement,
and its subject matter as required by SEC Rules, the disclosing party shall provide the non-disclosing party a copy of any proposed disclosure in advance in order to allow the non-disclosing party to redact any confidential or proprietary
information. 

 22. Restrictions; Reservation of Rights. 

 

	 	a.	Restrictions. Customer agrees that, unless otherwise expressly authorized in writing by Illumina: (i) the Consumables are intended for single-use only, and
(ii) any use of reagents other than the Consumables or reagents that Illumina has expressly authorized in writing to be used with the Goods voids all warranties and extended warranties for the Goods including, without limitation, the Hardware
Warranty found in Section 26 and Consumables Warranty found in Section 29. Customer agrees that Customer shall not, nor will Customer allow any third party to, engage in any of the following activities without the express prior written
permission of an officer of Illumina: (i) disassemble, reverse-engineer, reverse-compile, or reverse-assemble the Goods, (ii) separate, extract, or isolate components of Consumables or subject Consumables or components thereof to any
analysis not authorized by Illumina, (iii) otherwise gain access to or determine the methods of operation of the Goods, (iv) lease, sell, or resell any Goods, or (v) re-use Consumables. In addition to any other remedies available to
Illumina, a breach of this provision shall immediately terminate the rights, license(s), or permissions given hereunder and void all warranties including, without limitation, the rights conferred under Section 2 and all warranties under
Sections 26, 27, and 29. 

  

	 	b.	Software. Customer shall not (i) reproduce, modify or create derivative works of the Software, except as expressly permitted in the relevant EULA provided to
Customer, (ii) decompile, reverse engineer or otherwise attempt to gain unauthorized access to the Software source code, any Hardware or any component thereof or unbundle any embedded Software from any Hardware, (iii) use the Hardware,
component thereof, or the Software for third-party training, commercial time-sharing or service bureau use, or for any purpose other than as expressly authorized in Section 2 of this Agreement, (iv) remove, alter, cover or obfuscate any
copyright, trademark or other proprietary rights notices on or in the Goods, or (v) cause, authorize or permit any third party to do any of the foregoing. 

 

	 	c.	Documentation. Customer shall use the Documentation in accordance with the restrictions set forth therein, which may include but shall not be limited to restrictions
against altering, modifying or copying the Documentation or removing the Documentation from the Customer Facility without the prior written approval of Illumina, except that Customer shall be authorized to make any necessary copies of the
Documentation as required to support an application for FDA approval. Any permitted copies of the Documentation shall include Illumina’s copyright and other proprietary notices. 

 

	 	d.	Illumina Proprietary Information. Customer may only use the Illumina proprietary sequences (e.g., [...***...], and such other proprietary sequences as
Illumina may identify from time to time), with the Goods. 

  

	 	e.	Reservation of Rights. Illumina reserves all rights not expressly granted in this Agreement, and no licenses are granted by Illumina under this Agreement, whether by
implication, estoppel or otherwise, except as expressly set forth herein. 

 23. Indemnity. 

 

	 	a.	 Infringement. Except as set forth in Section 23(b), Illumina shall defend, indemnify and hold harmless Customer and its Subsidiaries and each of
their officers, directors and employees, against any third-party claim or action alleging that the Goods, when used in accordance with the terms and conditions of this Agreement infringe any valid and enforceable Intellectual Property Right, and
Illumina shall pay all settlements entered into, and all final judgments and costs (including reasonable attorneys’ fees) awarded against such indemnified party in connection with any such action. If the Goods or any part thereof,

  

					
		 		 	***Confidential Treatment Requested
		 	10	 	
		 	CONFIDENTIAL	 	

	 	
become, or in Illumina’s opinion may become, the subject of an infringement claim against Illumina or Customer, Illumina shall have the right, at its option, to (i) procure for Customer
the right to continue using such Goods, (ii) modify or replace such Goods with substantially equivalent noninfringing products, provided the modification or replacement is substantially equivalent to the replaced product, (iii) or, after
using [...***...] efforts to achieve the results in clauses (i) or (ii), require the return of such Goods and terminate the rights, license and any other permissions given hereunder with respect thereto and refund to Customer the
depreciated value of the Goods as shown in the financial records of Customer or price paid for such Goods, whichever is less. This Section 23 (a) states the entire liability of Illumina for any infringement of Intellectual Property Rights.

  

	 	b.	Exclusions. Illumina shall have no obligations to defend, indemnify or hold harmless Customer with respect to any third-party claim or action alleging that (i) the
use of the Goods, outside the scope of the rights, license(s), or permissions given by Illumina to Customer for such Goods, (ii) the use of the Goods, in combination with any other products or services not supplied by Illumina, (iii) the
use of the Goods to perform any assay or other process not supplied by Illumina, (iv) any Goods (or certain aspect thereof) provided hereunder in accordance with specifications or instructions furnished to Illumina by Customer (or by a third
party on behalf of Customer), (v) any act regarding the Goods in a manner not expressly authorized in this Agreement, or (vi) any Derivative Software or use of Derivative Software, in each of (i), (ii), (iii), (iv), (v) or
(vi) infringes any third party Intellectual Property Right (each of (i) – (vi) an (“Excluded Claim”). 

  

	 	c.	Indemnification by Illumina. Illumina shall defend, indemnify and hold harmless Customer and its Subsidiaries, and their respective officers, directors and employees,
against any third-party claim or action involving injury or death to a person or damage to tangible property and arising out of failure of the Goods to conform to their Specifications when such Goods are used for Research Use.

  

	 	d.	Indemnification by Customer. Customer shall defend, indemnify and hold harmless Illumina, and its officers, directors and employees, against (i) any third-party
claim or action that is, relates to, or arises out of an Excluded Claim, and (ii) any third party claims, liabilities, damages, fines, penalties, causes of action, and losses of any and every kind resulting from any use of the Goods for
Clinical Use including any failure to use the Goods in accordance with its Documentation and any failure of Customer to obtain and maintain the applicable regulatory approvals and licensure required for Customer’s intended uses of the Goods.

  

	 	e.	Conditions. The parties’ indemnification obligation pursuant to this Section 23 is subject to the party seeking indemnification (i) notifying the other
promptly in writing of such action, (ii) giving other party exclusive control and authority over the defense and settlement of such action, (iii) not admitting infringement of any Intellectual Property Right without prior written consent,
(iv) not entering into any settlement or compromise of any such action without the indemnifying party’s prior written consent, and (v) providing all reasonable assistance to the other party (provided that such party reimburses the
indemnified party for its reasonable out-of-pocket expenses incurred in providing such assistance); provided, that the indemnifying party may not enter into any settlement that admits fault on the part of the indemnified party and does not include a
release within the scope of the claim that is the subject of the action for which the indemnified party is obligated to indemnify hereunder. 

  

	 	f.	Third-Party Goods. Notwithstanding anything herein to the contrary, Illumina shall have no indemnification obligations with respect to any goods or software originating
from a third party and provided under this Agreement. Customer’s sole right to indemnification with respect to such third party goods or software shall be pursuant to the original manufacturer’s or licensor’s indemnity, if any, to
Customer, to the extent provided by the original manufacturer or licensor. 

 24. Shelf-life.
[...***...], all Consumables shall have no less than [...***...] ([...***...])[...***...] shelf life at the time of shipment. 
 25. Additional Instrument Service and Support. If Customer desires additional service and support for Hardware, Customer and Illumina will execute a separate service and support agreement.

  

					
		 		 	***Confidential Treatment Requested
		 	11	 	
		 	CONFIDENTIAL	 	

 26. Warranty for Hardware. The “Hardware Warranty Period” shall be for a period of
[...***...] ([...***...]) months. In the case of Hardware that includes installation, the Hardware Warranty Period shall commence upon installation of the Hardware. For all other Hardware, the Hardware Warranty Period
commences upon delivery. During the Hardware Warranty Period, the Hardware (other than Software, the warranty for which is set forth in Section 27) will conform to the Specifications. This limited warranty extends only to Customer as original
purchaser unless otherwise agreed upon in writing by Illumina. 
 The foregoing warranty shall not apply if the Hardware or any
component thereof (i) has been subjected to abuse, misuse, neglect, negligence, accident, improper testing, improper installation, improper storage, improper handling or use contrary to any instructions issued by Illumina or has been used in
any manner inconsistent with the rights conferred upon Customer under this Agreement, (ii) has been repaired, altered, disassembled or reassembled, or removed from the Facility by persons not expressly authorized by Illumina, (iii) has not
been installed, operated, repaired and maintained in accordance with the Documentation, (iv) has failed due to an act of God, including but not limited to fire, flood, tornado, earthquake, hurricane, lightning, threat of or actual acts of
terrorism or war, or (v) has been used with any third party software, hardware, or item including, without limitation, reagent which has not been previously approved in writing by Illumina. If during the Hardware Warranty Period:
(i) Illumina’s authorized service or support representative is notified promptly upon discovery of any failure of the Hardware to conform to the warranty set forth in this Section, including a detailed description of such alleged failure,
(ii) at Illumina’s option, either access to the Hardware is provided to Illumina on-site at the Facility or such applicable component(s) are returned, transportation charges prepaid, to Illumina’s designated facility in accordance
with Illumina’s then-current return procedures, and (iii) Illumina’s inspections and tests determine that the Hardware or the applicable component indeed fails to conform and has not been subjected to any of the conditions set forth
in this Section, then, as Customer’s sole remedy (except for any indemnification obligations of Illumina pursuant to Section 23(a) and 23(c)) and Illumina’s sole obligation under the foregoing warranty, Illumina will, at
Illumina’s option, repair or replace without charge the Hardware or applicable component(s). Any Hardware or component that has either been repaired or replaced under this warranty shall have warranty coverage for the longer of
[...***...] ([...***...]) days or [...***...]. Repairs may include the replacement of parts with functionally equivalent, reconditioned or new parts. 
 27. Software Warranty. The Software will substantially conform to its Specifications for the warranty period specified in the EULA provided with the Software, but in any event no longer than the
[...***...]; provided that Customer maintains a software release level within one major release of the most current release of the Software. Customer’s sole remedy and Illumina’s sole obligation under the foregoing warranty
shall be for Illumina to use [...***...] efforts to correct any substantial nonconformity of the Software reported to Illumina’s authorized service or support representative by Customer during the warranty period. The foregoing
warranty shall not apply to any failure to conform by the Software that is caused by (i) the use or operation of the Software in an environment other than that advised or recommended by Illumina, (ii) modifications to the Software not made
or authorized by Illumina, or (iii) third party hardware or software, whether provided by Illumina or any third party. In addition, the foregoing warranty shall not apply to any Software which has been used with any third party hardware or
software or to any Derivative Software. 
 28. Third-Party Goods. Notwithstanding anything herein to the contrary, Illumina makes no
warranty with respect to any third-party goods provided under this Agreement. Customer’s sole remedy with respect to such third-party goods shall be pursuant to the original manufacturer’s or licensor’s warranty, if any, to Customer,
to the extent permitted by the original manufacturer or licensor. 
 29. Warranty for Consumables. The Consumables, will conform to the
Specifications until the later of (i) [...***...] ([...***...]) months from the date of delivery, or (ii) any expiration date or the end of the shelf-life pre-printed on such Consumable by Illumina, but in no
event later than [...***...] ([...***...]) months from [...***...] (the “Consumable Warranty Period”). This limited warranty extends only to Customer, as original purchaser unless otherwise
agreed upon in writing by Illumina. The foregoing warranties shall not apply if any Consumable (a) has been subjected to abuse, misuse, neglect, negligence, accident, improper testing, improper installation, improper storage, improper handling
or use contrary to any instructions issued by Illumina or has been used in any manner inconsistent with the rights conferred upon Customer under this Agreement, (b) has been repaired, altered, disassembled or reassembled, (c) has not been
operated, repaired and maintained in accordance with the Documentation, (d) has failed due to an act of God, including but not limited to fire, flood, tornado, earthquake, hurricane, lightning, threat of or actual acts of terrorism or war, or
(e) has been used with any third party good not provided under this or any other agreement with Illumina. If during the Consumable Warranty Period: (a) Illumina’s 

  

					
		 		 	***Confidential Treatment Requested
		 	12	 	
		 	CONFIDENTIAL	 	

 
authorized service or support representative is notified promptly upon discovery of any failure of such Consumable to conform to the warranty set forth in this Section, including a detailed
description of such alleged failure, (b) such Consumable is returned, transportation charges prepaid, to Illumina’s designated facility in accordance with Illumina’s then-current return procedures, and (c) Illumina’s
inspections and tests determine that such Consumable indeed fails to conform and has not been subjected to any of the conditions set forth in this Section, then, as Customer’s sole remedy (except for any indemnification obligations of Illumina
pursuant to Section 23(a) and 23(c)) and Illumina’s sole obligation under the foregoing warranty, Illumina will, at Illumina’s option, repair or replace without charge such Consumable. Any Consumable that has either been repaired or
replaced under this warranty shall have warranty coverage for the longer of [...***...] ([...***...]) days or [...***...]. 
 30. Term; Cancellation; Termination. 
  

	 	a.	Term. This Agreement shall commence on the Effective Date and terminate three (3) years thereafter (the “Term”) unless otherwise terminated early as
provided hereunder. 

  

	 	b.	Cancellation of Orders. Except as set forth in Section 32.g., all Purchase Orders are non-cancelable and may not be modified without the prior written consent of
Illumina. 

  

	 	c.	Termination. If either party breaches a material provision of this Agreement and fails to cure such breach within thirty (30) days after receiving written notice
of the breach, the non-breaching party shall have the right to terminate this Agreement at any time by providing written notice to the other party. Either party may terminate this Agreement, effective immediately upon written notice, if the other
party becomes the subject of a voluntary or involuntary petition in bankruptcy or any proceeding relating to insolvency, receivership, liquidation or composition for the benefit of creditors that is not dismissed within sixty (60) days. In the
event of any bankruptcy or insolvency proceeding commenced by or against Customer, Illumina shall be entitled to cancel any order then outstanding. 

 31. Survival of Obligations. All provisions of this Agreement that by their nature should survive termination shall survive including without limitation Sections 1, 2, 3, 5, 13, 16, 19, 20, 21, 22,
23, 26-29, 31, 32, and all payment obligations incurred hereunder. All other rights and obligations of the parties under this Agreement shall cease upon termination or expiration of this Agreement. 

32. Miscellaneous. 
  

	 	a.	Customer acknowledges and agrees that any future products and/or services (“Unreleased Products”) are subject to new part numbers, pricing, and
specifications. Customer agrees that its purchase of the Goods hereunder is not in reliance on the availability of any Unreleased Products. Customer acknowledges that Customer has no right to return any Goods except as expressly provided hereunder.

  

	 	b.	If any provision of this Agreement is held invalid or unenforceable, such provision shall be enforced to the maximum extent permissible so as to effect the intent of
the parties, and the remainder of this Agreement will continue in full force and effect. The failure of either party to exercise any right granted herein or to require any performance of any term of this Agreement or the waiver by either party of
any breach of this Agreement shall not prevent a subsequent exercise or enforcement of, or be deemed a waiver of any subsequent breach of, the same or any other term of this Agreement. Nothing in this Agreement shall constitute or create a joint
venture, partnership, or any other similar arrangement between the parties. No party is authorized to act as agent for the other party hereunder except as expressly stated in this Agreement. 

 

	 	c.	Customer acknowledges and agrees that the Goods provided under this Agreement may be subject to restrictions and controls imposed by the United States Export
Administration Act and the regulations thereunder (or the regulations and laws of another country). Customer agrees not to export or re-export the Goods, or any related technology into any country in violation of such controls or any other laws,
rules or regulations of any country, state or jurisdiction. 

  

	 	d.	 All notices required or permitted under this Agreement shall be in writing and shall be deemed received when (a) delivered personally;
(b) five (5) days after having been sent by registered or certified mail, return 

  

					
		 		 	***Confidential Treatment Requested
		 	13	 	
		 	CONFIDENTIAL	 	

	 	
receipt requested, postage prepaid (or ten (10) days for international mail); or (c) one (1) day after deposit with a commercial express courier specifying next day delivery or,
for international courier packages, two (2) days after deposit with a commercial express courier specifying 2-day delivery, with written verification of receipt. All notices shall be sent to the following or any other address designated by a
party using the procedures set forth in this sub-section: 

 If to Illumina 

Illumina, Inc. 

9885 Towne Center Drive 
 San Diego, CA 92121 
 Attn: VP of Sales 

With a copy to: 
 Illumina, Inc. 
 9885 Towne Centre Drive 

San Diego, CA 92121 
 Attn: General Counsel 
 If to Customer 

Sequenom, Inc. 

3595 John Hopkins Court 
 San Diego, CA 92121 
 Attn: SVP Diagnostic Operations 

With a copy to: 
 Sequenom, Inc. 
 3595 John Hopkins Court 

San Diego, CA 92121 
 Attn: General Counsel 
  

	 	e.	Neither party shall assign or transfer this Agreement or any rights or obligations under this Agreement, whether voluntary, by operation of law or otherwise, without
the prior written consent of the other party; provided, however, that either party may assign or transfer this agreement to any successor by way of merger, acquisition or sale of all or substantially all of its stock or assets relating to this
Agreement. Illumina or any successor may assign all or part of the right to payments under this Agreement. Any assignment or transfer of this Agreement made in contravention of the terms hereof shall be null and void. Subject to the
foregoing, this Agreement shall be binding on and inure to the benefit of the parties’ respective successors and permitted assigns. 

  

	 	f.	This Agreement and performance by the parties hereunder shall be construed in accordance with the laws of the State of California, U.S.A., without regard to provisions
on the conflicts of laws. 

  

	 	g.	 Illumina shall not be responsible for any failure to perform or delay attributable in whole or in part to any cause beyond its reasonable control,
including but not limited to acts of God, fire, flood, tornado, earthquake, hurricane, lightning, government actions, actual or threatened acts of war, terrorism, civil disturbance or insurrection, sabotage, labor shortages or disputes, failure or
delay in delivery by Illumina’s suppliers or subcontractors, transportation difficulties, shortage of energy, raw materials or equipment, or Customer’s fault or negligence; provided, however, that Customer may terminate any Purchase Order
for which the delivery of the Goods subject to such Purchase Order has been delayed for more than [...***...] ([...***...]) days as a result of such force majeure event. In the event of any such delay the delivery date
shall be deferred for a period equal to the time lost by reason of the delay. Except with respect 

  

					
		 		 	***Confidential Treatment Requested
		 	14	 	
		 	CONFIDENTIAL	 	

	 	
to its obligations to pay any amounts due under this Agreement, Customer shall not be responsible for any failure to perform or otherwise attributable in whole or in part to any cause beyond its
reasonable control, including but not limited to acts of God, fire, flood, tornado, earthquake, hurricane, lightning, government actions, actual or threatened acts of war, terrorism, civil disturbance or insurrection, sabotage, labor shortages or
disputes. 

  

	 	h.	This Agreement represents the entire agreement between the parties regarding the subject matter hereof and supersedes all prior discussions, communications, agreements,
and understandings of any kind and nature between the parties. No amendment to this Agreement or waiver of any right, condition, or breach will be effective unless in writing and signed by both parties. 

 

									
	 Sequenom Inc.:
	 	  	 	 Illumina Inc.:

					
	By:	 	 /s/ Harry F. Hixson Jr., Ph.D.
	 		 	By:	  	 /s/ Nick Naclerio

			
	Name: Harry F. Hixson Jr., Ph.D.	 		 	Name: Nick Naclerio
			
	Title: Chief Executive Officer	 		 	Title: SVP, Corporate & Venture Development
					
	Date:	 	7/8/2011	 		 	Date: 	  	7/8/2011

  

					
		 	15	 	
		 	CONFIDENTIAL	 	

 Exhibit A 
 Consumables 
 V3 Bundles 

 

									
	 Part Number
	 	 Description
	  	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
		 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
		 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
		 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
		 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]
		 	[...***...]	  	[...***...]	 	[...***...]	 	[...***...]

 [...***...] 
 Consumables Purchase Price 
 Consumables will be bundled and priced based on
[...***...]. 
 Consumable Spend 
 Consumable Spend will be determined at the beginning of each calendar Quarter as follows: [...***...]. 
 [...***...] 
 [...***...] 

(Note, this pricing applies to [...***...]. The pricing for the [...***...] is separate and distinct from this, and detailed in
Appendix I herein.) 
  

  

					
		 		 	***Confidential Treatment Requested
		 	EX. A-1	 	                    CONFIDENTIAL

 Instruments 

 

					
	 Part Number
	  	Description	  	List Price as of Effective Date of this Agreement
	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	[...***...]	  	[...***...]

 Instrument Purchase Price 
 The purchase prices for Instruments are given in the table below. [...***...]  
 By
way of example, [...***...]. 
  

											
	 Tier
	  	 Cumulative Purchase Threshold
	  	 Part Number
	  	 Description
	  	 Price
	  	 [...***...]

	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]

	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]

	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]

	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]
	  	 [...***...]

  

					
		 		 	***Confidential Treatment Requested
		 	EX. A-2	 	                    CONFIDENTIAL

 Software 

 

					
	 Description
	  	Where Used	 	Version
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]

  

  

					
		 		 	***Confidential Treatment Requested
		 	EX. A-3	 	                    CONFIDENTIAL

 Exhibit B 
 Illumina Facilities 
 The table below lists the manufacturing locations for the parts
listed as of the date of execution of this Agreement. The abbreviations in the table refer to the Illumina manufacturing sites listed below, along with their mailing addresses. 

 

							
	 1.
	  	SDQ	  		  	 Illumina Inc.
 9885
Towne Centre Drive
 San Diego, CA 92121 USA
 (this address will change over the course of the next 12-24 months as Illumina moves to its new site)

				
	 2.
	  	HWD	  		  	 Illumina Hayward

25861 Industrial Blvd.
 Hayward, CA 94545
USA

				
	 3.
	  	SGI	  		  	 Illumina Singapore

29 Woodlands Industrial Park E1
 North Tech,
Lobby 3, #02-13/18
 Singapore 757716

  

					
	 Part Number
	  	Descriptions	 	Manufacturing site (s)
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]

  

					
		 		 	***Confidential Treatment Requested
		 	EX. B-1	 	                    CONFIDENTIAL

					
	[...***...]	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]
	 [...***...]
	  	[...***...]	 	[...***...]

  

					
		 		 	***Confidential Treatment Requested
		 	EX. B-2	 	                    CONFIDENTIAL

 Exhibit C 
 [...***...] INSTALLATION TESTING 
 [...***...] installation Testing:

  

	 	•	 	 Illumina will confirm that your instrument is fully functional on-site at your laboratory. An Illumina Field Service Engineer will install the hardware
and perform functional testing as described below. 

  

	 	•	 	 Installation is completed when the equipment has passed the following tests and Illumina confirms that the instrument conforms to Illumina’s
Specifications for the instrument: 

 [...***...] 

  

					
		 		 	***Confidential Treatment Requested
		 	EX. C-1	 	                    CONFIDENTIAL

 Appendix I 
 Initial [...***...] Consumable Purchase 
  

													
	 Kit Descriptions
	  	 Part Number
	  	Spls/ Kit	  	List $ /Kit	  	[...***...]	  	[...***...]	  	Total at List
Price
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		  		  		  		  		  	[...***...]
	 [...***...]
	  		  		  		  		  	[...***...]	  	[...***...]
	 [...***...]
	  		  		  		  		  		  	[...***...]
	 [...***...]
	  		  		  		  		  		  	[...***...]
	 [...***...]
	  		  		  		  		  		  	[...***...]

  

					
		 		 	***Confidential Treatment Requested
		 	A-1	 	                    CONFIDENTIAL

 Appendix II 

 

							
	Asset Type	  	Asset Name	  	Serial Number	  	Install Date
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	  	[...***...]	  	[...***...]

  

					
		 		 	***Confidential Treatment Requested
		 	A-1	 	                    CONFIDENTIAL

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]